{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:48:25Z","timestamp":1792000105046,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011300","name":"Department of Pediatrics, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijid.2021.06.045","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T08:49:35Z","timestamp":1624524575000},"page":"279-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study"],"prefix":"10.1016","volume":"109","author":[{"given":"Birger","family":"Trollfors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignir","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dahlgren-Aronsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.06.045_bib0001","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1930","article-title":"Interferon-\u03b3 Release Assays in Children <15 Years of Age","volume":"145","author":"Ahmed","year":"2020","journal-title":"Pediatrics"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2021.06.045_bib0002","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","author":"Barreto","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.ijid.2021.06.045_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2013different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0004","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/joim.13084","article-title":"BCG scarring and improved child survival: a combined analysis of studies of BCG scarring","volume":"288","author":"Benn","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijid.2021.06.045_bib0005","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Bourdin Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.06.045_bib0006","first-page":"137","article-title":"Waning of BCG scar and its implications","volume":"40","author":"Channabasavaiah","year":"1993","journal-title":"Indian J Tuberculosis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0007","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3122\/jabfm.2014.05.140062","article-title":"Advances in diagnosis and treatment of latent tuberculosis infection","volume":"27","author":"Chapman","year":"2014","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.ijid.2021.06.045_bib0008","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG Vaccine in the Prevention of Tuberculosis Meta-analysis of the Published Literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.06.045_bib0009","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What Have We Learnt about BCG Vaccination in the Last 20\u2009Years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2021.06.045_bib0010","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.0365","article-title":"Making wider use of the world's most widely used vaccine: Bacille Calmette\u2013Gu\u00e9rin revaccination reconsidered","volume":"10","author":"Dye","year":"2013","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.ijid.2021.06.045_bib0011","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oxfordjournals.bmb.a072277","article-title":"BCG vaccination against tuberculosis and leprosy","volume":"44","author":"Fine","year":"1988","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ijid.2021.06.045_bib0012","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.06.045_bib0013","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/00365540701732905","article-title":"BCG scar and tuberculin reactivity in children and adults","volume":"40","author":"Fj\u00e4llbrant","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0014","first-page":"57","article-title":"Bacille Calmette Gu\u00e9rin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects","volume":"36","author":"Fritschi","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ijid.2021.06.045_bib0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12879-016-1872-9","article-title":"Relation between BCG vaccine scar and an interferon-gamma release in immigrant children with \"positive\" tuberculin skin test (\u226510 mm)","volume":"16","author":"Gudj\u00f3nsd\u00f3ttir","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0016","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.2.6082.293","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Final report to the Medical Research Council","volume":"2","author":"Hart","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.ijid.2021.06.045_bib0017","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiz430","article-title":"Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: A cross-sectional analysis of a UK-based cohort","volume":"221","author":"Katelaris","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0018","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(17)30248-7","article-title":"Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA","volume":"17","author":"LoBue","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0019","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1753465813503028","article-title":"Treatment of latent tuberculosis infection","volume":"7","author":"Madhavi","year":"2013","journal-title":"Adv Respir Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"C Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0021","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/thoraxjnl-2014-205688","article-title":"The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland","volume":"69","author":"Michelsen","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2021.06.045_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.045_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2021.06.045_bib0025","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2021.06.045_bib0026","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.201201-0026OC","article-title":"Identifying Predictors of Interferon-gamma Release Assay Results in Pediatric Latent Tuberculosis: A Protective Role of Bacillus Calmette-Gu\u00e9rin? A pTB-NET Collaborative Study","volume":"186","author":"Roy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2021.06.045_bib0027","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tube.2015.04.003","article-title":"Latent tuberculosis infection\u2013Revisiting and revising concepts","volume":"95","author":"Salgame","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ijid.2021.06.045_bib0028","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1183\/09031936.93.03020187","article-title":"Revaccination with BCG: its effects on skin tests in Kuwaiti senior school children","volume":"3","author":"Shaaban","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2021.06.045_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/apa.12121","article-title":"Spread of tuberculosis in a high school","volume":"102","author":"Trollfors","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ijid.2021.06.045_bib0031","first-page":"819","article-title":"Trial of BCG vaccines in south India for tuberculosis prevention: First report 144","volume":"57","year":"1979","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2021.06.045_bib0032","unstructured":"Who.int. GHO | By category | BCG - Immunization coverage estimates by country, 2020. https:\/\/apps.who.int\/gho\/data\/node.main.A830?lang=en"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:59:57Z","timestamp":1761119997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221005348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"alternative-id":["S1201971221005348"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.06.045","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}